MedPath

周至年青保制药有限公司

Ownership
-
Established
1995-08-21
Employees
-
Market Cap
-
Website
http://www.nianqingbao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

50

NMPA:50

Drug Approvals

半夏止咳糖浆

Approval Number
国药准字Z20063584
Approval Date
Jan 4, 2024
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H20046686
Approval Date
May 9, 2022
NMPA

Hypromellose Eye Drops

Product Name
羟丙甲纤维素滴眼液
Approval Number
国药准字H20103788
Approval Date
May 9, 2022
NMPA

Ribavirin Eye Drops

Product Name
利巴韦林滴眼液
Approval Number
国药准字H20058671
Approval Date
May 9, 2022
NMPA

Phenobarbital Tablets

Product Name
苯巴比妥片
Approval Number
国药准字H20046693
Approval Date
May 9, 2022
NMPA

Diprophylline Tablets

Product Name
二羟丙茶碱片
Approval Number
国药准字H20046691
Approval Date
May 9, 2022
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H20046695
Approval Date
May 9, 2022
NMPA

Compound Rutin Tablets

Product Name
复方芦丁片
Approval Number
国药准字H20046696
Approval Date
May 9, 2022
NMPA

Compound Diclofenac Sodium and Chlorphenamine Maleate Tablets

Product Name
氯芬黄敏片
Approval Number
国药准字H20046692
Approval Date
May 9, 2022
NMPA

Compound Aspirin Tablets

Product Name
复方乙酰水杨酸片
Approval Number
国药准字H20046688
Approval Date
May 9, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.